期刊
TRENDS IN BIOCHEMICAL SCIENCES
卷 44, 期 5, 页码 401-414出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2019.01.001
关键词
-
资金
- Chinese NSFC [81430071, 81790251, 81821002, 81872277, 81602194]
- National 973 Basic Research Program of China [2013CB911300]
Metabolic alterations and elevated levels of reactive oxygen species (ROS) are two characteristics of cancer. The metabolic patterns of cancer cells are elaborately reprogrammed to fulfill the high biomass demands of rapid propagation. ROS, the byproducts of metabolic processes, are accumulated in cancer cells partially due to metabolic abnormalities or oncogenic mutations. To prevent oxidative damage, cancer cells can orchestrate metabolic adaptation to maintain reduction-oxidation (redox) balance by producing reducing equivalents. ROS, acting as second messengers, can in turn manipulate metabolic pathways by directly or indirectly affecting the function of metabolic enzymes. In this review we discuss how cancer cell metabolism and redox signaling are intertwined, with an emphasis on the perspective of targeting metabolic-redox circuits for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据